Hong Kong-listed AI drug discovery company Insilico Medicine and Eli Lilly sign a drug co-development deal worth up to $2.75B, with $115M in upfront payments
CNBC Evelyn Cheng
Related Coverage
- Mounjaro maker signs $2.7 billion deal on AI drug research The Economic Times
- Lilly, Insilico Ink Deal on AI Drugs Worth Up to $2.75 Billion Bloomberg · Madison Muller
- Eli Lilly Strikes AI Drug Discovery Deal With InSilico Worth Up to $2.75 Billion — Update Dow Jones Newswires · Jason Chau
- Mounjaro maker signs $2.7 bln deal on AI drug research Hürriyet Daily News
- Eli Lilly signs $2bn deal for AI drug development with Hong Kong biotech Financial Times · Patrick Temple-West
- Eli Lilly extends partnership with Insilico Medicine for AI-powered drug discovery Reuters · Christy Santhosh
- Eli Lilly leans into AI drug discovery with new licensing deal Semafor · J.D. Capelouto
- AI drug developer Insilico Medicine and Lilly ink commercialization deal worth up to $2.75 billion STAT · Brittany Trang
- Eli Lilly Secures $2.75 Billion Deal With Insilico Medicine To Bring AI-Developed Drugs To Global Market: Report Benzinga · Rounak Jain
- Hong Kong-listed Insilico Medicine signs AI drug development deal with Eli Lilly South China Morning Post · Julie Zhang
- Insilico Medicine Announces 2025 Annual Results, Redefining Value Delivery in AI-Powered Drug Discovery Insilico Medicine
- Eli Lilly signs $2.75 billion deal with AI drug developer Insilico Medicine The Decoder · Matthias Bastian
- Insilico Medicine secures $2.75 billion drug collaboration with Eli Lilly Reuters · Rishabh Jaiswal
- Eli Lilly to sign $2 billion deal for AI drug development with Hong Kong biotech Yahoo Finance · Patrick Temple-West
- Amazing deals are being revealed in the drug discovery and design sector. Eli Lilly and Company just announced a $2.75 billion deal … Sertac Yeltekin
- These Stocks Are Today's Movers: Nvidia, Eli Lilly, Alcoa, Coinbase, Strategy, and More Barron's Online · George Glover
Discussion
-
@andrewcurran_
Andrew Curran
on x
Their CEO, Alex Zhavoronkov, told CNBC that Insilico has already developed at least 28 drugs using generative AI tools, with nearly half already at a clinical stage. They develop their models in Canada and the ME, and then conduct the early preclinical drug development in China. …
-
r/business
r
on reddit
Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market
-
r/technology
r
on reddit
Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market
-
r/wallstreetbets
r
on reddit
Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market